About this trial
This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.
Eligibility criteria
Qualifiers
Women 25-49 years
Accessing HIV care and treatment services
Not being pregnant
Patients with a cervix
Disqualifiers
Physical or mental impairment that inhibits participation in the study
Pregnant women or <6 weeks post-partum
Women who have undergone a total hysterectomy with removal of the cervix
Trial design
Treatments tested in this trial
- HPV DNA testing be self-collected vaginal swab
Treatment groups
Sponsors and collaborators
Tulane University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
National Institutes of Health (NIH)
Collaborator